News & Blog

Tag Archives: GBM

Top Five Blogs: July – September 2019

Below is a recap of the most popular brain tumor news and blog items from Q3 2019 (July – Sept.) on the NBTS site, as measured by YOUR readership and views. We hope you’ll enjoy catching up on anything you may have missed! 1. A Missing Link to Glioblastoma Growth? Research funded through NBTS’s Defeat […]

Can Newly Approved “Tissue Agnostic” Drugs Benefit Pediatric High-grade Glioma Patients?

Recently, the U.S. Food and Drug Administration (FDA) granted accelerated approval* to the drug Rozlytrek (entrectinib, Genentech/Roche**) as a treatment for patients, 12 years or older, whose tumors have a specific genetic defect known as an “NTRK gene fusion.”*** This is now the second drug that the FDA has approved to treat patients with this […]

Guest Blog: “I would have given anything to trade places with him”

On a family vacation in 2011, Mac tried to catch a seagull. Using his boogie board to shield his movements, he inched his way across the sand, closing on his target. With the determination and strong-will that defined him, Mac patiently stalked his target for 20 minutes, taking great care with each step as to […]

Share